{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:46:34Z","timestamp":1762249594352},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:00:00Z","timestamp":1498348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Chang Gung Memorial Hospital, Taiwan, ROC","award":["CMRPG360251-3","CMRPG391381-3","CMRPG3C1931","CMRPG3E1221"],"award-info":[{"award-number":["CMRPG360251-3","CMRPG391381-3","CMRPG3C1931","CMRPG3E1221"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bj.2017.06.006","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T23:47:00Z","timestamp":1501199220000},"page":"212-218","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Progesterone analogues reduce plasma Epstein\u2013Barr virus DNA load and improve pain control in recurrent\/metastatic nasopharyngeal carcinoma patients under supportive care"],"prefix":"10.1016","volume":"40","author":[{"given":"Chia-Yen","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tung-Liang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Chia","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hsun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Lung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2017.06.006_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bj.2017.06.006_bib2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjc.6601620","article-title":"Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids","volume":"90","author":"Moses","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bj.2017.06.006_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.bj.2017.06.006_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bj.2017.06.006_bib5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bj.2017.06.006_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000441-193211000-00002","article-title":"The immediate causes of death in cancer","volume":"184","author":"Warren","year":"1932","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bj.2017.06.006_bib7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0360-3016(01)02782-1","article-title":"Supportive use of megestrol acetate (Megace) with head\/neck and lung cancer patients receiving radiation therapy","volume":"52","author":"McQuellon","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bj.2017.06.006_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2011\/601434","article-title":"Cancer cachexia: mechanisms and clinical implications","volume":"2011","author":"Donohoe","year":"2011","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.bj.2017.06.006_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-8140(97)01921-X","article-title":"Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy","volume":"43","author":"Chen","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bj.2017.06.006_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hed.20447","article-title":"Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment","volume":"29","author":"Couch","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.bj.2017.06.006_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004310.pub3","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","volume":"3","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bj.2017.06.006_bib12","doi-asserted-by":"crossref","first-page":"M48","DOI":"10.1093\/gerona\/56.1.M48","article-title":"The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients","volume":"56","author":"Yeh","year":"2001","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.bj.2017.06.006_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/ajcn.70.2.183","article-title":"Geriatric cachexia: the role of cytokines","volume":"70","author":"Yeh","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bj.2017.06.006_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1044579X02000925","article-title":"Treatment strategy and clinical experience","volume":"12","author":"Teo","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bj.2017.06.006_bib15","first-page":"1355","article-title":"Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia","volume":"146","author":"Pathmanathan","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bj.2017.06.006_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199509143331103","article-title":"Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma","volume":"333","author":"Pathmanathan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bj.2017.06.006_bib17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/91.9.796","article-title":"Nasopharyngeal brush biopsies and detection of nasopharyngeal cancer in a high-risk population","volume":"91","author":"Tune","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bj.2017.06.006_bib18","first-page":"1188","article-title":"Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma","volume":"59","author":"Lo","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.bj.2017.06.006_bib19","first-page":"6878","article-title":"Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA","volume":"60","author":"Lo","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bj.2017.06.006_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2001.tb03865.x","article-title":"Quantitative analysis of Epstein-Barr virus DNA in plasma and serum: applications to tumor detection and monitoring","volume":"945","author":"Lo","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bj.2017.06.006_bib21","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hed.21890","article-title":"Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma","volume":"34","author":"Hsu","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.bj.2017.06.006_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.oraloncology.2013.02.006","article-title":"Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma","volume":"49","author":"Hsu","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bj.2017.06.006_bib23","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/jnci\/94.21.1614","article-title":"Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma","volume":"94","author":"Chan","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bj.2017.06.006_bib24","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa032260","article-title":"Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma","volume":"350","author":"Lin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bj.2017.06.006_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.1984.2.3.187","article-title":"Karnofsky performance status revisited: reliability, validity, and guidelines","volume":"2","author":"Schag","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bj.2017.06.006_bib26","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11606-007-0321-2","article-title":"Accuracy of the pain numeric rating scale as a screening test in primary care","volume":"22","author":"Krebs","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.bj.2017.06.006_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0959-8049(97)10090-9","article-title":"Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?","volume":"34","author":"Andreyev","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bj.2017.06.006_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-121-6-199409150-00001","article-title":"Megestrol acetate in patients with AIDS-related cachexia","volume":"121","author":"Von Roenn","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bj.2017.06.006_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1200\/JCO.1993.11.1.152","article-title":"Body-composition changes in patients who gain weight while receiving megestrol acetate","volume":"11","author":"Loprinzi","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bj.2017.06.006_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(94)90229-1","article-title":"Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations","volume":"265","author":"McCarthy","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bj.2017.06.006_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1615\/CritRevOncog.v9.i2.10","article-title":"Cytokine involvement in cancer anorexia\/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms","volume":"9","author":"Mantovani","year":"1998","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.bj.2017.06.006_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/SPC.0b013e3283186be2","article-title":"Cachexia, survival and the acute phase response","volume":"2","author":"Stephens","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.bj.2017.06.006_bib33","first-page":"665","article-title":"Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma","volume":"4","author":"Mutirangura","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bj.2017.06.006_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.1992.10.2.257","article-title":"A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck","volume":"10","author":"Jacobs","year":"1992","journal-title":"J Clin Oncol"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S231941701730224X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S231941701730224X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T18:40:03Z","timestamp":1569955203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S231941701730224X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S231941701730224X"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2017.06.006","relation":{},"ISSN":["2319-4170"],"issn-type":[{"type":"print","value":"2319-4170"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progesterone analogues reduce plasma Epstein\u2013Barr virus DNA load and improve pain control in recurrent\/metastatic nasopharyngeal carcinoma patients under supportive care","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2017.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Chang Gung University. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}